U.S. Healthcare Services Stock News

Veeva Systems (NYSE:VEEV) has secured new enterprise agreements from Kindeva Drug Delivery, Teva Pharmaceuticals, and Merck KGaA for its Quality Cloud and Vault CRM platforms. The company has also introduced Veeva Falcon, an agentic platform with AI driven workflow tools focused on key drug development activities. These client wins and product developments indicate deeper adoption of Veeva’s software across large global biopharma companies. For investors watching Veeva Systems, the fresh...

Salesforce (CRM) opened fiscal Q1 2027 with revenue of US$11.1 billion and basic EPS of US$2.43, while over the last 12 months revenue has reached US$42.8 billion and basic EPS stands at US$8.65. The company has seen revenue move from US$9.8 billion and EPS of US$1.61 in Q1 2026 to US$11.1 billion and EPS of US$2.43 in Q1 2027, which may lead investors to focus on how much of that top line is dropping through to profit and what the margin profile suggests about the quality of the growth. See...

Millicom International Cellular (TIGO) has drawn attention after recent trading, with the stock last closing at US$83.83. Investors are weighing this price against the company’s fundamentals as well as its exposure to Latin American telecom markets. See our latest analysis for Millicom International Cellular. While the share price has eased over 1 day and over the past week, the stock still carries a 90-day share price return of 15.01%, alongside a very large 3-year total shareholder return...

If you are wondering whether Levi Strauss stock still offers value after its recent run, or if you might be late to the party, this article explains what the current price appears to reflect. The stock last closed at US$23.72, with returns of 9.1% over 7 days, 6.4% over 30 days, 13.9% year to date, 37.2% over 1 year and 98.0% over 3 years, compared with 2.2% over 5 years. Recent coverage has focused on Levi Strauss as a global consumer brand and on how investors are reassessing established...

Why Cytokinetics (CYTK) is on investors’ radar Cytokinetics (CYTK) has attracted fresh investor attention after a strong move in the stock over the past month, prompting a closer look at how its current valuation lines up with fundamentals. See our latest analysis for Cytokinetics. At a share price of $76.81, Cytokinetics has delivered a strong 30 day share price return of 26.6% and a very large 1 year total shareholder return of 145.2%, pointing to building momentum as investors reassess its...

FirstEnergy's Ohio utilities have submitted a three year rate plan to state regulators that outlines major grid upgrades and expanded customer assistance programs. The filing details substantial planned investment in the electrical grid along with proposals for gradual distribution rate changes for Ohio customers. The plan will go through a regulatory review and public comment process that could influence the final structure of customer rates and assistance offerings. For investors watching...

Some investors may be wondering if WEC Energy Group stock at around US$111.67 is offering fair value right now, or if the price is getting ahead of itself. Over the very short term the stock is relatively flat, declining 0.4% over the last week and 3.5% over the last month, while the year to date return sits at 4.9% and the 1 year return at 8.9%, with 3 and 5 year returns of 44.3% and 40.9% respectively. Recent coverage of WEC Energy Group has focused on its position in the regulated...

Genpact (NYSE:G) has been placed in the highest tier by HFS Research for its work in orchestrating and transforming Global Capability Centers. The recognition centers on Genpact's use of AI and platform-led services to support these centers. The ranking underscores the company's role in helping enterprises manage complex operational requirements through Global Capability Centers. For you as an investor, this recognition sits at the intersection of business process management, AI and global...

In recent days, AppLovin drew heightened attention after strong first-quarter results and broad analyst optimism coincided with anticipation for the June 2026 launch of its Axon AI-powered self-serve advertising platform. A distinctive angle in this story is Meta Platforms’ decision to avoid bidding on key non-IDFA iOS ad inventory, spotlighting AppLovin’s AXON engine as a relative advantage in a technically complex segment of mobile advertising. We'll now explore how the Axon AI platform...

Shareholders of Bath & Body Works, Inc. ( NYSE:BBWI ) will be pleased this week, given that the stock price is up 18...

It looks like Agnico Eagle Mines Limited ( NYSE:AEM ) is about to go ex-dividend in the next two days. The ex-dividend...

Tyson Foods, Inc. ( NYSE:TSN ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

BorgWarner Inc. ( NYSE:BWA ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

Q1 2026 earnings snapshot sets the stage for Autohome (NYSE:ATHM) Autohome (NYSE:ATHM) opened 2026 with Q1 revenue of C¥1,048.4 million and basic EPS of C¥0.38, alongside net income of C¥44.3 million, putting fresh numbers behind a stock currently trading at $17.30. Over the last few quarters, revenue has moved from C¥1,783.4 million in Q4 2024 to C¥1,453.8 million in Q1 2025 and then to C¥1,048.4 million in Q1 2026, while quarterly basic EPS has shifted from C¥2.51 to C¥2.86 and then to...

Wondering if Sociedad Química y Minera de Chile at around US$84.05 is still offering value after a strong run, or if you are arriving late to the story. The stock has returned 6.0% over the past week, is down 6.0% over the past month, but is up 20.5% year to date and 169.1% over the last year, which can change how the market is thinking about its risk and reward profile. Recent coverage has focused on Sociedad Química y Minera de Chile as a key player in materials and lithium related themes,...

Recent price performance and business profile Kemper (KMPR) has been under pressure recently, with the stock down 3% over the past day and 14% over the past week. This has drawn attention to how its insurance business is currently positioned. The company offers specialty auto and life insurance products across the United States through two main segments: Specialty Property & Casualty Insurance and Life Insurance. Total revenue was reported at US$4.7b. See our latest analysis for...

Agilent Technologies (A) has just reported Q2 2026 results with revenue of US$1,835 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$7.2 billion and EPS of US$5.00 that sit against a one year earnings growth figure of 21.3%. Over recent quarters, revenue has ranged between US$1,668 million and US$1,861 million while quarterly EPS has moved between roughly US$0.75 and US$1.53, with net profit margin across the last year at 19.6% compared to 17.6% a year earlier...

AI momentum and federal cloud access put Cellebrite DI (NasdaqGS:CLBT) in focus Fresh headlines around broader adoption of Cellebrite DI (NasdaqGS:CLBT) AI and cloud-based investigation tools, plus FedRAMP authorization for its cloud platform, have put the stock back onto investor watchlists. Project Genesis, the company’s new AI tool aimed at cutting investigation times, is seeing early customer interest, and recent updates highlight growth in annual recurring revenue along with a thicker...

If you are trying to figure out whether GE Vernova is attractively priced or already fully valued, the recent share performance gives you a lot to think about. The stock recently closed at US$996.00, with returns of 46.6% year to date and 111.9% over the last year, even though it is down 4.6% over the past week and 8.5% over the past month. Recent coverage has focused on GE Vernova as a standalone listed business following its separation from General Electric. Investors are watching how the...

At its May 20, 2026 annual meeting, Five9 shareholders approved amendments to the company’s charter to declassify the Board of Directors and eliminate supermajority voting requirements, meaning all directors will now stand for election more frequently under standard voting thresholds. This shift materially strengthens shareholder rights and board accountability, potentially making Five9 more responsive to investor input on governance, capital allocation, and long-term corporate...

Momentus (MNTS) has drawn fresh attention after entering securities purchase agreements with existing institutional investors for a private placement of 2,942,000 shares. The transaction is expected to raise about US$25,000,000 in gross proceeds. See our latest analysis for Momentus. The private placement and recent shelf registrations have arrived after a sharp swing in sentiment, with the 30 day share price return of 278.91% and year to date share price return of 237.98% contrasting with a...

Investors may wish to note that the Chief Revenue Officer of TechTarget, Inc. , Steven Niemiec, recently netted US$95k...

Wondering if Forgent Power Solutions at around US$47.56 is offering value or stretching expectations? This article walks through what the current price might be telling you. The stock has eased about 2% over the past week, but is still up 28.9% over the past month and 64.0% year to date, which can change how you think about both upside and risk. Recent coverage has focused on Forgent Power Solutions as investors look more closely at power and grid related companies, with attention on how its...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...